News

Back

Univercells Technologies completes Nivelles facility expansion, tripling manufacturing and R&D capacity

October 5th 2022

BSCB Dev

Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has completed a EUR 2 m expansion of the Nivelles, Belgium site. The critical investment was made to deliver a deeper level of support and supply chain security to biomanufacturers.

Read Pdf